Skip to main content
Premium Trial:

Request an Annual Quote

NuTec Partners to Build Zebrafish Database, Bioinformatics Software in Two New Deals

Premium

NuTec Sciences of Atlanta, Ga., recently boosted its life science activities through two new partnerships: a collaboration with Zygogen to build a database of zebrafish genome data, and another with Daresbury Laboratory to develop simulation software with applications in bioinformatics.

Under the partnership with Zygogen of Atlanta, Ga., NuTec will help design the zebrafish database, called Z-base, as well as add new sequence information, and “structure it in a more friendly way,” according to Nina Sawczuk, CEO of Zygogen. Z-base is currently in preliminary form.

In addition, NuTec will write algorithms for performing comparative genomics studies with the human genome. Sawczuk added that Zygogen would add the sequence data as it becomes available.

Zygogen plans to use the database to identify genes in humans associated with diseases such as angiogenesis, neurodegenerative, and cardiovascular disease.

At Daresbury, which is part of the UK’s Central Laboratory of the Research Councils, NuTec’s European subsidiary will work with the lab’s computational science and engineering group to develop simulation software with a number of applications, including bioinformatics. NuTec is also supplying hardware to Daresbury and will support the development of applications able to run on the Grid, a network of distributed computers through which researchers will share data.

The software project will build on simulation software NuTec developed for the oil and gas industry. Daresbury will extend its capability in that field, and will also apply the software to data mining of 3D molecular shapes in order to compare them to potential drug compounds and predict binding activity. The software will also combine additional types of information, such as how the compound behaves in the bloodstream

“[NuTec has] made real advances in computational simulation for the oil industry and we can jointly extend our mutual skills to benefit life sciences and bioinformatics,” said Paul Durham, director of computational science and engineering at Daresbury.

A Daresbury spokesman declined to comment on the proposed terms of access to the software.

— JSM and BT

Filed under

The Scan

Removal Inquiry

The Wall Street Journal reports that US lawmakers are seeking additional information about the request to remove SARS-CoV-2 sequence data from a database run by the National Institutes of Health.

Likely to End in Spring

Free lateral flow testing for SARS-CoV-2 may end in the UK by next spring, the head of Innova Medical Group says, according to the Financial Times.

Searching for More Codes

NPR reports that the US Department of Justice has accused an insurance and a data mining company of fraud.

Genome Biology Papers on GWAS Fine-Mapping Method, COVID-19 Susceptibility, Rheumatoid Arthritis

In Genome Biology this week: integrative fine-mapping approach, analysis of locus linked to COVID-19 susceptibility and severity, and more.